Literature DB >> 18614443

Significance of bronchoscopic lung biopsy in clinical practice.

E Danila1, E Zurauskas, G Loskutoviene, R Zablockis, R Nargela, V Birzietyte, G Valentinaviciene.   

Abstract

PURPOSE: At present bronchoscopic lung biopsy (BLB) is widely used to diagnose various lung diseases. However placing of BLB in the diagnostic sequence of various clinical situations is not so clear. The purpose of the study was to evaluate the diagnostic value of BLB in a daily clinical practice.
MATERIAL AND METHODS: The data obtained from the case records of all 304 patients who had undergone BLB since January 1996 to December 2007 at the Centre of Pulmonology and Allergology of Vilnius University Hospital Santariskiu klinikos (Vilnius, Lithuania) were examined.
RESULTS: Most of indications for BLB were a peripheral lung nodule (40% of all the cases), dissemination in the lung (24% of all BLBs) and non-resolving pulmonary infiltrates (16.3% of all biopsies). Adequate lung tissue for histological examination was obtained in 85% of the cases. Based on the pathological diagnosis and findings of other diagnostic methods the final clinical diagnosis was verified for most of the patients. However, at least in 8% of the cases, the final clinical diagnosis was yet syndromic. Of all the BLBs, serious complications occurred in 8 (2.6%) patients. Clinically significant pneumothorax requiring chest tube treatment occurred in 5 (1.6%) of 304 patients. Severe bleeding occurred in 3 (1%) out of all BLBs.
CONCLUSION: BLB is a relatively effective and safe method for diagnosing lung diseases. In most cases of the lung infiltrate, nodule, dissemination and diffuse changes, BLB is suitable to choose method for lung biopsy.

Entities:  

Mesh:

Year:  2008        PMID: 18614443     DOI: 10.2478/v10039-008-0011-2

Source DB:  PubMed          Journal:  Adv Med Sci        ISSN: 1896-1126            Impact factor:   3.287


  2 in total

1.  CD31+, CD38+, CD44+, and CD103+ lymphocytes in peripheral blood, bronchoalveolar lavage fluid and lung biopsy tissue in sarcoid patients and controls.

Authors:  Regina Aleksonienė; Justinas Besusparis; Vygantas Gruslys; Laimutė Jurgauskienė; Aida Laurinavičienė; Arvydas Laurinavičius; Radvilė Malickaitė; Jolita Norkūnienė; Rolandas Zablockis; Edvardas Žurauskas; Edvardas Danila
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

2.  Age as a Risk Factor in the Occurrence of Complications during or after Bronchoscopic Lung Biopsy.

Authors:  Irina Pocienė; Rasa Gauronskaitė; Domantas Galkauskas; Antanas Mainelis; Vygantas Gruslys; Edvardas Danila
Journal:  Geriatrics (Basel)       Date:  2022-03-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.